Itinai.com biomedical laboratory close up still scene close u 2a5a1238 15e1 44d7 ad99 fe42b30c4e72 0
Itinai.com biomedical laboratory close up still scene close u 2a5a1238 15e1 44d7 ad99 fe42b30c4e72 0

A Randomized Hybrid-Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx-ACT) Trial

A Randomized Trial on Pharmacogenomics for Chronic Pain Treatment

Study Overview

This trial explored the impact of pharmacogenomic (PGx) results on patients with chronic pain in primary care, comparing it to standard treatment methods. It was a largely virtual study where participants were divided into two groups: one receiving PGx care and the other receiving standard care.

Participants and Method

Adults experiencing pain for at least three months and treated with tramadol, codeine, or hydrocodone took part in the trial. Alternative pain medications were suggested for patients identified as CYP2D6 intermediate or poor metabolizers. A total of 253 participants were included in the study.

Key Findings

The analysis focused on changes in pain intensity over three months. Results showed:

  • No significant difference in pain intensity between the PGx group and the standard care group (-0.10 vs. -0.21; p = 0.74).
  • 69% of PGx participants received care aligned with their genetic results compared to 63% in standard care.
  • In patients with poor metabolism, those receiving PGx-aligned care showed a slight improvement in pain intensity compared to those who did not align (change of -0.21 vs. -0.06).

Conclusion

The trial indicates that using PGx information did not significantly change prescribing practices or overall clinical outcomes. However, there was a slight improvement in pain intensity for those whose treatment aligned with PGx recommendations. Future research should focus on effective ways to implement PGx in clinical settings.

Practical Solutions and Value

Clinical trials are essential for developing effective treatments. To maximize these benefits in everyday practice, we introduce DocSym, an AI-driven platform that:

  • Consolidates clinical standards and research into one accessible resource.
  • Supports healthcare operations through mobile apps for scheduling, treatment monitoring, and telemedicine.
  • Enhances clinic workflows, improves patient outcomes, and reduces paperwork.

Discover how DocSym can assist your practice at aidevmd.com.

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research